< 生产厂家价格 >

盐酸正丙胺

盐酸正丙胺名称

[ CAS 号 ]:
556-53-6

[ 中文名 ]:
盐酸丙胺

[ 英文名 ]:
Propan-1-aminium chloride

[中文别名 ]:

[英文别名 ]:

1-Propanamine, hydrochloride (1:1)
MFCD00012911
1-Propanamine hydrochloride (1:1)
Propan-1-aminium chloride
Propan-1-amine hydrochloride (1:1)
EINECS 209-129-9
1-Propanamine hydrochloride
propan-1-amine,hydrochloride

盐酸正丙胺物理化学性质

[ 沸点 ]:
46.9ºC at 760 mmHg

[ 熔点 ]:
160-162 °C(lit.)

[ 分子式 ]:
C₃H₁₀ClN

[ 分子量 ]:
95.571

[ 精确质量 ]:
95.050179

[ PSA ]:
26.02000

[ LogP ]:
1.85740

[ 外观性状 ]:
白色至非常略米色结晶粉末

[ 储存条件 ]:
存放于惰性气体之中;避免湿气 (吸湿)

盐酸正丙胺MSDS

盐酸正丙胺毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: UI3057000

CHEMICAL NAME :: Propylamine, hydrochloride

CAS REGISTRY NUMBER :: 556-53-6

LAST UPDATED :: 199701

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C3-H9-N.Cl-H

MOLECULAR WEIGHT :: 95.59

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1545 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- Volume(issue)/page/year: 97,1117,1977

点击显示

盐酸正丙胺安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302-H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xn: Harmful;

[ 风险声明 (欧洲) ]:
R22

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ RTECS号 ]:
UI3057000

盐酸正丙胺合成路线

盐酸正丙胺上下游产品

盐酸正丙胺上游产品

盐酸正丙胺下游产品

盐酸正丙胺文献

High-performance liquid chromatographic behaviour of some pharmaceutically important thiazide, loop and potassium-sparing diuretics.

J. Chromatogr. A. 325(2) , 395-411, (1985)

This paper deals with the specific identification of several thiazide, potassium-sparing and loop diuretics. The liquid chromatographic behaviour of these compounds is studied. Different organic modif...

Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.

Neuropsychopharmacology 39(8) , 1996-2007, (2014)

Drug interaction between inhibitors of monoamine oxidase (MAOIs) and selective serotonin (5-hydroxytryptamine, 5-HT) reuptake (SSRIs) induces serotonin syndrome, which is usually mild but occasionally...

更多文献